Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Saba Rasouli"'
Publikováno v:
Advanced Pharmaceutical Bulletin, Vol 13, Iss 3, Pp 592-600 (2023)
Purpose: Teduglutide is the first and only FDA-approved drug for long-term treatment of short bowel syndrome (SBS). The current study aimed to present an approach for production of teduglutide using recombinant DNA technology. Methods: The coding gen
Externí odkaz:
https://doaj.org/article/55ae25c3538d41cbb7d4172498f7ec70
Publikováno v:
Infectious Disease Modelling, Vol 7, Iss 4, Pp 761-776 (2022)
Objective: Covid-19 is a highly contagious viral infection that has recently become a pandemic. Since the beginning of the pandemic, the disease has affected millions of people and taken many people's lives. The purpose of this paper is to predict an
Externí odkaz:
https://doaj.org/article/44cafa2de1e64d3f8a022a107434aae9
Publikováno v:
Advanced Pharmaceutical Bulletin.
Purpose: Teduglutide is the first and only FDA-approved drug for long-term treatment of short bowel syndrome (SBS). The current study aimed to present an approach for production of teduglutide using recombinant DNA technology. Methods: The coding gen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f9d79e640d1d47b69e0f96abeb411cbd
https://doi.org/10.34172/apb.2023.064
https://doi.org/10.34172/apb.2023.064